Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Jul;142(1):265-266.
doi: 10.1378/chest.12-0423.

Preventing VTE in Outpatients With Cancer

Alok A Khorana  1 , Alex C Spyropoulos  2 , Jeffrey Zwicker  3 , Gary H Lyman  4 , Charles W Francis  2
Affiliations
Comment

Preventing VTE in Outpatients With Cancer

Alok A Khorana et al. Chest. 2012 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Zwicker has received funding support from Sanofi-Aventis US LLC. Dr Lyman is co-chair and Drs Khorana and Francis are members of the American Society of Clinical Oncology VTE Guidelines Panel. Dr Francis is a member of a steering committee for a study sponsored by Eisai Co, Ltd, and participates in a registry sponsored by Eisai Co, Ltd. Dr Spyropoulos has reported that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

Comment on

References

    1. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(suppl):e195S-e226S - PMC - PubMed
    1. Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011;103(17):1299-1309 - PubMed
    1. Hurwitz HI, Saltz LB, Van Cutsem E, et al. Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies. J Clin Oncol. 2011;29(13):1757-1764 - PubMed
    1. Khorana AA. Risk assessment and prophylaxis for VTE in cancer patients. J Natl Compr Canc Netw. 2011;9(7):789-797 - PubMed
    1. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, eds; Committee on Standards for Developing Trustworthy Clinical Practice Guidelines ; Board on Health Care Services ; Institute of Medicine of the National Academies Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011 - PubMed

MeSH terms

Substances